MICHAEL F COLA
CIK 1188940 · Chief Executive Officer · last filed 2026-05-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$893.3K
Companies
9
Total Filings
69
Lifetime Open-Market Net
$1.36M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PHAT | Director | 63,920 | $10.37 | $662.9K | $186.2K | 8 | 2026-05-21 |
| Sage Therapeutics, Inc. (SAGE) Delisted | Director | — | $8.68 | — | $0 | 13 | 2025-07-31 |
| AVTX | Chief Executive Officer | — | $14.76 | — | $0 | 1 | 2021-10-04 |
| Avalo Therapeutics, Inc. (CERC) Delisted | Chief Executive Officer | 175,746 | $2.93 | $514.9K | $250.0K | 9 | 2021-07-02 |
| Aevi Genomic Medicine, LLC (GNMX) Delisted | President and CEO | 2,267,859 | — | — | $424.6K | 7 | 2019-12-09 |
| VNDA | Director | 15,000 | $5.87 | $88.0K | $0 | 7 | 2019-06-17 |
| Aevi Genomic Medicine, LLC (MDGN) Delisted | President and CEO | — | — | — | $0 | 1 | 2016-04-19 |
| Aevi Genomic Medicine, LLC (MDGN.WS) Delisted | President and CEO | 99,436 | — | — | $500.0K | 4 | 2015-10-08 |
| PATH | Director | 13,500 | $10.55 | $142.4K | $0 | 16 | 2014-01-03 |
Recent Filings · Page 4 of 7
69 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-06-18 | Aevi Genomic Medicine, LLC (GNMX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-15 | VNDA | Grant (A) | +5,000 | $0 | EDGAR |
| 2018-06-08 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-16 | Aevi Genomic Medicine, LLC (GNMX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-16 | Aevi Genomic Medicine, LLC (GNMX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-10-18 | Aevi Genomic Medicine, LLC (GNMX) Delisted | Buy (P) | +119,047 | $150.0K | EDGAR |
| 2017-08-15 | Aevi Genomic Medicine, LLC (GNMX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-19 | VNDA | Grant (A) | +5,000 | $0 | EDGAR |
| 2017-06-08 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-02-17 | Aevi Genomic Medicine, LLC (GNMX) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.